1. Special Advisory Committee on the Epidemic of Opioid Overdoses. Opioid and stimulant-related harms in Canada. Ottawa: Public Health Agency of Canada; December 2021. 2021. Available from: https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/. Accessed 8 Feb 2022.
2. British Columbia Coroners Service. Illicit drug toxicity deaths in BC January 1, 2011 – May 31, 2022. 2021. Available from: https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicit-drug.pdf. Accessed 14 Jul 2022.
3. Bowles JM, McDonald K, Maghsoudi N, Thompson H, Stefan C, Beriault DR, et al. Xylazine detected in unregulated opioids and drug administration equipment in Toronto, Canada: clinical and social implications. Harm Reduct J. 2021;18(1):104.
4. Purssell R, Buxton J, Godwin J, Moe J. Potent sedatives in opioids in BC: implications for resuscitation, and benzodiazepine and etizolam withdrawal | British Columbia Medical Journal. 2021. Available from: https://bcmj.org/bccdc/potent-sedatives-opioids-bc-implications-resuscitation-and-benzodiazepine-and-etizolam. Accessed 7 Mar 2022.
5. Bardwell G, Collins AB, McNeil R, Boyd J. Housing and overdose: an opportunity for the scale-up of overdose prevention interventions? Harm Reduct J. 2017;14(1):77.